Idiopathic inflammatory myopathies
IE Lundberg, M Fujimoto, J Vencovsky… - Nature Reviews …, 2021 - nature.com
Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …
group of autoimmune disorders with varying clinical manifestations, treatment responses …
Update on outcome assessment in myositis
The adult and juvenile myositis syndromes, commonly referred to collectively as idiopathic
inflammatory myopathies (IIMs), are systemic autoimmune diseases with the hallmarks of …
inflammatory myopathies (IIMs), are systemic autoimmune diseases with the hallmarks of …
Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEV1, exacerbations, oral corticosteroids, symptoms …
LP de Llano, I Dávila, E Martínez-Moragón… - The Journal of Allergy …, 2021 - Elsevier
Background There is a lack of tools to quantify the response to monoclonal antibodies
(mAbs) holistically in severe uncontrolled asthma patients. Objective To develop a valid …
(mAbs) holistically in severe uncontrolled asthma patients. Objective To develop a valid …
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis
RP Goswami, SN Haldar, M Chatterjee, P Vij… - Autoimmunity …, 2022 - Elsevier
Objective To perform a systematic review and meta-analysis on the efficacy and safety of
intravenous (IVIg) and subcutaneous (SCIg) immunoglobulin (Ig) therapy in the treatment of …
intravenous (IVIg) and subcutaneous (SCIg) immunoglobulin (Ig) therapy in the treatment of …
Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy
B Rockette-Wagner, D Saygin, S Moghadam-Kia… - …, 2021 - academic.oup.com
Abstract Objective Idiopathic inflammatory myopathies (IIMs) cause proximal muscle
weakness, which affects the ability to carry out the activities of daily living. Wearable physical …
weakness, which affects the ability to carry out the activities of daily living. Wearable physical …
Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis
Objective To describe decline in muscle strength and physical function in patients with
sporadic inclusion body myositis (IBM). Methods Manual muscle testing (MMT), quantitative …
sporadic inclusion body myositis (IBM). Methods Manual muscle testing (MMT), quantitative …
[HTML][HTML] Current Biomarker Strategies in Autoimmune Neuromuscular Diseases
M Oeztuerk, A Henes, CB Schroeter, C Nelke, P Quint… - Cells, 2023 - mdpi.com
Inflammatory neuromuscular disorders encompass a diverse group of immune-mediated
diseases with varying clinical manifestations and treatment responses. The identification of …
diseases with varying clinical manifestations and treatment responses. The identification of …
Updates on juvenile dermatomyositis from the last decade: classification to outcomes
H Kim, AM Huber, S Kim - Rheumatic Disease Clinics, 2021 - rheumatic.theclinics.com
Juvenile dermatomyositis (JDM) is a rare heterogeneous immune-medicated condition with
characteristic skin rashes, muscle weakness, vasculopathy, and other organ involvement …
characteristic skin rashes, muscle weakness, vasculopathy, and other organ involvement …
Peculiar clinicopathological features of immune-mediated necrotizing myopathies
Y Allenbach, O Benveniste - Current opinion in rheumatology, 2018 - journals.lww.com
IMNM are muscle-specific autoimmune diseases associated with a severe weakness and a
risk poor muscle strength recovery. Anti-SRP and anti-HMGCR antibodies are specifically …
risk poor muscle strength recovery. Anti-SRP and anti-HMGCR antibodies are specifically …
[HTML][HTML] Use of machine learning models to predict prognosis of combined pulmonary fibrosis and emphysema in a Chinese population
Q Liu, D Sun, Y Wang, P Li, T Jiang, L Dai… - BMC Pulmonary …, 2022 - Springer
Background Combined pulmonary fibrosis and emphysema (CPFE) is a novel clinical entity
with a poor prognosis. This study aimed to develop a clinical nomogram model to predict the …
with a poor prognosis. This study aimed to develop a clinical nomogram model to predict the …